---
figid: PMC5445378__13046_2017_541_Fig3_HTML
figlink: /pmc/articles/PMC5445378/figure/Fig3/
number: Fig. 3
caption: Interferon synthesis and signaling pathways. Interferons are crucial molecules
  for creating antiviral status. E5 stimulates IFN synthesis through activation of
  NF-κB signalling pathway and IRF-1 protein. (1) PRR/MAVS (Mitochondrial antiviral
  signaling) activates IKK that liberates NF-κB. (2) NF-κB, IRF-3 and ATF-2/c-Jun
  form a transcriptional complex that recruits the (3) CPB/P300 enhancer to IFN-β
  promoter. (4) This complex (along with IRF-1) binds to (5) particular DNA regions
  (PRDI, PRDII and PRDIV) which results in (6) IFN-β gene transcription. In IFN-independent
  way, (7) viral dsRNA induces (8) PKR-IRF3 signalling. The produced IFNs exert their
  activities in keratinocytes by (9) interacting with specific IFN-type receptor and
  (10) triggering JAK/STAT signalling pathways. IFN-α, IFN-β and IFN-λ interact with
  receptors associated with JAK1 and Tyk2 tyrosine kinases which induce the activation
  and dimer formation of the transcriptional factor STAT1/STAT2 by phosphorylation.
  This dimer forms a complex with IFN-stimulatory gene factor- 3γ (ISGF-3γ), also
  called IFN regulatory factor-9 (IRF-9) or P48, which bind to the ISRE sequence of
  DNA. In turn, IFN-γ binds to receptors associated with Jak1 and Jak2 tyrosine kinases
  that induce the formation of the Stat1/Stat1 homodimer. Finally, (11) the binding
  of transcription factors to specific responsive elements (i.e. ISRE and GAS) of
  DNA leads to (12) ISGs expression []. This IFN-induced activities create an antiviral
  state which leads to the destruction of infected cells with episomal HPV [], whereas
  cells with integrated viral DNA can survive and transcription of E6-E7 oncogenes
  are no longer regulated by E2 leading to persistent infection and cancer formation
  []
pmcid: PMC5445378
papertitle: 'hrHPV E5 oncoprotein: immune evasion and related immunotherapies.'
reftext: Antonio Carlos de Freitas, et al. J Exp Clin Cancer Res. 2017;36:71.
pmc_ranked_result_index: '13012'
pathway_score: 0.9376599
filename: 13046_2017_541_Fig3_HTML.jpg
figtitle: Interferon synthesis and signaling pathways
year: '2017'
organisms: Homo sapiens
ndex: 605af405-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5445378__13046_2017_541_Fig3_HTML.html
  '@type': Dataset
  description: Interferon synthesis and signaling pathways. Interferons are crucial
    molecules for creating antiviral status. E5 stimulates IFN synthesis through activation
    of NF-κB signalling pathway and IRF-1 protein. (1) PRR/MAVS (Mitochondrial antiviral
    signaling) activates IKK that liberates NF-κB. (2) NF-κB, IRF-3 and ATF-2/c-Jun
    form a transcriptional complex that recruits the (3) CPB/P300 enhancer to IFN-β
    promoter. (4) This complex (along with IRF-1) binds to (5) particular DNA regions
    (PRDI, PRDII and PRDIV) which results in (6) IFN-β gene transcription. In IFN-independent
    way, (7) viral dsRNA induces (8) PKR-IRF3 signalling. The produced IFNs exert
    their activities in keratinocytes by (9) interacting with specific IFN-type receptor
    and (10) triggering JAK/STAT signalling pathways. IFN-α, IFN-β and IFN-λ interact
    with receptors associated with JAK1 and Tyk2 tyrosine kinases which induce the
    activation and dimer formation of the transcriptional factor STAT1/STAT2 by phosphorylation.
    This dimer forms a complex with IFN-stimulatory gene factor- 3γ (ISGF-3γ), also
    called IFN regulatory factor-9 (IRF-9) or P48, which bind to the ISRE sequence
    of DNA. In turn, IFN-γ binds to receptors associated with Jak1 and Jak2 tyrosine
    kinases that induce the formation of the Stat1/Stat1 homodimer. Finally, (11)
    the binding of transcription factors to specific responsive elements (i.e. ISRE
    and GAS) of DNA leads to (12) ISGs expression []. This IFN-induced activities
    create an antiviral state which leads to the destruction of infected cells with
    episomal HPV [], whereas cells with integrated viral DNA can survive and transcription
    of E6-E7 oncogenes are no longer regulated by E2 leading to persistent infection
    and cancer formation []
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNAR1
  - GAST
  - JUN
  - IFNGR1
  - IFNAR2
  - STAT1
  - IFNA1
  - IFNB1
  - ATF2
  - IFNA6
  - IFNA2
  - EIF2AK2
  - IFNA5
  - JAK3
  - STAT2
  - IFNA4
  - NKRF
  - EP300
  - TYK2
  - JAK2
  - IFNGR2
  - IFNW1
  - IFNK
  - IFNA16
  - IFNA17
  - IKBKG
  - IL10RB
  - NFKBIA
  - IFNA21
  - IFNA10
  - IRF1
  - IFNA7
  - IFNA8
  - CHUK
  - IKBKB
  - JAK1
  - IFNA13
  - IFNA14
  - IRF9
  - IRF3
genes:
- word: IFNAR1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: IFNAR
  symbol: IFNAR
  source: hgnc_prev_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: GAS
  symbol: GAS
  source: hgnc_prev_symbol
  hgnc_symbol: GAST
  entrez: '2520'
- word: C-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: IFNGR1
  symbol: IFNGR1
  source: hgnc_symbol
  hgnc_symbol: IFNGR1
  entrez: '3459'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFN-A
  symbol: IFN-ALPHA
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFN-B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: ATF-2/
  symbol: ATF2
  source: hgnc_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: PKR
  symbol: PKR
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK2
  entrez: '5610'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: NRF
  symbol: NRF
  source: hgnc_alias_symbol
  hgnc_symbol: NKRF
  entrez: '55922'
- word: P300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TyK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFNGR2
  symbol: IFNGR2
  source: hgnc_symbol
  hgnc_symbol: IFNGR2
  entrez: '3460'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNW1
  entrez: '3467'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNK
  entrez: '56832'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IL-10R2
  symbol: IL-10R2
  source: hgnc_alias_symbol
  hgnc_symbol: IL10RB
  entrez: '3588'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: IRF-1
  symbol: IRF1
  source: hgnc_symbol
  hgnc_symbol: IRF1
  entrez: '3659'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: ISGF-3
  symbol: ISGF-3
  source: hgnc_alias_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: Interferon
  symbol: Interferon
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: IRF-9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: IRF-3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
chemicals: []
diseases: []
---
